Form 4 for DBD DIEBOLD NIXDORF, Inc
Accepted 2022-03-10 00:00:00 ET · period of report 2022-03-08 · accession 0000028823-22-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-10 | 2022-03-08 | DBD | RUTHERFORD JEFFREY L | EVP, CFO | A - Grant | $0.00 | +185.4K | 413.1K | +81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-03-08 | A | A | 185,383 | $0.00 | 413,143 | D | — | — | (F1) Award of restricted stock units; each restricted stock unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock. (F2) Number includes restricted stock units. |